Correlates of immune protection induced by live, attenuated, cold- adapted, trivalent, intranasal influenza virus vaccine

Journal of Infectious Diseases

Volumn 181, Issue 3, 2000, Pages 1133-1137

  Belshe, Robert B ^a,m   Gruber, William C ^b   Mendelman, Paul M ^c   Mehta, Harshvardhan B ^c   Mahmood, Kutubuddin ^c   Reisinger, Keith ^e   Treanor, John ^f   Zangwill, Ken ^d   Hayden, Frederick G ^g   Bernstein, David I ^h   Kotloff, Karen ^j   King, James ^k   Piedra, Pedro A ⁱ   Block, Stan L ^j   Yan, Lihan ^l   Wolff, Mark ^l  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c MEDIMMUNE   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e NIOSH Pittsburgh Research Laboratory   (United States)

^f UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^g UNIVERSITY OF VIRGINIA   (United States)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j Kentucky Pediatric Research Institute   (United States)

^k UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^l EMMES CORPORATION   (United States)

^m S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; VIRUS SHEDDING;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; COLD; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOGLOBULIN A; INFANT; INFLUENZA A VIRUS; INFLUENZA VACCINES; MACACA MULATTA; VACCINATION; VACCINES, ATTENUATED;

EID: 0034083593     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315323     Document Type: Article

References (15)

1. 1. Nichol KL, Mendelman PM, Mallon KP, et al. for the Live Attenuated Influenza Virus Vaccine in Healthy Adults Trial Group. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999; 282:137-45.
2. 2. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998; 338:1405-12.
3. 3. Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of annual vaccination with live attenuated, cold-adapted, trivalent intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000; 136:168-75.
4. 4. Clancy RL. Mucosal vaccines for the prevention of influenza. Drugs 1995; 50:587-94.
5. 5. WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza. The 1995-96 WHO Influenza Reagent Kit for the Identification of Influenza Isolates, Appendix A. Atlanta, GA: Centers for Disease Control and Prevention, 1995:15-9.
6. 6. Boyce TG, Gruber WC, Coleman-Dockery SD, et al. Mucosal immune responses to trivalent live attenuated intranasal influenza vaccine in children. Vaccine 1999; 18:82-8.
7. 7. Edwards KM, Dupont WD, Westrich MK, Plummer WD Jr, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994; 169: 68-76.
8. 8. Yarchoan R, Strober W, Murphy BR, Nelson DL. In vitro production of IgA antibody by human lymphocytes. In: Strober W, Lamm ME, McGhee JR, James S, eds. Mucosal Immunity and Infections at Mucosal Surfaces. New York: Oxford University Press, 1988:94-102.
9. 9. Edmondson WP Jr, Rothenberg R, White PW, Gwaltney JM Jr. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge. Am J Epidemiol 1971; 93:480-6.
10. 10. Evans AS. Serologic studies of acute respiratory infections in military personnel. Yale J Biol Med 1975; 48:201-9.
11. 2/Hong Kong influenza vaccine efficacy 14 months after immunization. JAMA 1971; 217:1067-71.
12. 12. Fox JP, Cooney MK, Hall CE, Hjordis MF. Influenza virus infections in Seattle families, 1975-1979. Am J Epidemiol 1982; 116:228-42.
13. 13. Clements ML, Betts RF, Tierney EL, Murphy BR. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol 1986; 24:157-60.
14. 14. Potter CW. Determinants of immunity to influenza infection in man. Br Med Bull 1979; 35:69-73.
15. 15. National Institutes of Health. Specific immunity in influenza - summary of Influenza Workshop III. J Infect Dis 1973; 127:220-36.